Skip to content

Intergard IGW0032-15Recalls & reported problems

Intervascular Sas · Intergard Woven Straight Collagen Coated Vascular Graft · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00384401000273), received between Jun 13, 2017 and Mar 27, 2019 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Manufacturing, Packaging or Shipping Problem” (1 report).

1 other recall cover devices cleared under the same FDA submission (K984294); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Manufacturing, Packaging or Shipping Problem1
  • Product Quality Problem1

Patient problems

  • Blood Loss1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 27, 2019Product Quality Problem; Product Quality Problem

    ACCORDING TO THE SURGEON, THE SURGERY DID NOT HAPPEN AS USUAL. THE INVOLVED GRAFT WAS NOT FLEXIBLE AND WAS DIFFICULT TO HANDLE INTRAOPERATIVELY. A SMALL SAMPLE OF THE GRAFT WAS RETURNED FOR EXAMINATION. IT IS UNKNOWN IF A PORTION OF THE GRAFT REMAINED IMPLANTED. PATIENT WAS NEITHER INJURED NOR ENDANGERED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8456821 ↗
  • InjuryJun 13, 2017Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem

    DURING A SURGERY PERFORMED ON (B)(6) 2017, A BLOOD LEAKING OCCURRED. IT WAS REPORTED THAT WHEN PUTTING IN PLACE THE GRAFT, THE SURGEON NOTICED THAT THE GRAFT WAS PERMEABLE (UNUSUAL BEHAVIOUR). THE SURGEON HAD TO USE A SUBSTANTIAL AMOUNT OF SURGICEL (HEMOSTATIC AGENT) TO STOP THE BLEEDING. THE HAEMOSTASIS WAS DIFFICULT TO CONTROL. THE PRODUCT REMAINED IMPLANTED. NO CLINICAL CONSEQUENCE FOR THE PATIENT WAS REPORTED.

    Patient problems: Blood Loss

    MAUDE report 6636906 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K984294. One submission often covers many models, so check the product and lot details in each record.

  • Z-1282-2022 · Apr 29, 2022 · Terminated
    INTERGARD Woven Vascular Graft is a woven polyester graft coated with a bovine collagen. It has an external velour surface and non-velour inner surface. The device is available in

Other Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices

All Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page